The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee.
Abstract
Prestudy patient characteristics and specific therapy of all eligible patients with rhabdomyosarcoma entered into Intergroup Rhabdomyosarcoma (RMS) Studies I (IRS-I) (1972 to 1978, n = 686) or II (IRS-II) (1978 to 1984, n = 1,002) were examined for their relationship to survival within each of the four clinical groups using univariate and multivariate analyses. The estimated survival at 5 years from the start of treatment was 56% in IRS-I and 62% in IRS-II (P = .006). The largest survival difference between studies was in patients with group III tumors (52% v 65%). The clinical group was the most important patient characteristic related to survival in both studies. Survival progressively decreased for patients from clinical group I (localized disease, completely resected) to group IV (metastatic disease at the onset). In clinical group I, the only patient characteristic consistently related to survival was histology. Patients with alveolar tumors had the poorest survival, while those with botryoid/embryonal lesions had the best survival. In clinical group II, no characteristic was consistently related to survival. In clinical group III, an orbital primary site was associated with a favorable survival. In clinical group IV, patients with genitourinary tumors had a significant survival advantage. Use of disease-free survival as an end point gave very similar results. This information, from the largest available data base on prognostic indicators in childhood RMS in the context of aggressive multimodal therapies, is being used to plan therapy in the forthcoming study (IRS-IV).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Look, A. T., Hayes, F. A., Nitschke, R., McWilliams, N. B., & Green, A. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407263110405 · Cited by 491
Lawrence, W., Gehan, E. A., Hays, D. M., Beltangady, M., & Maurer, H. M. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.1.46 · Cited by 188
Self-citationRaney, R. B., Crist, W., Maurer, H. M., & Foulkes, M. A. (2006) · Cancer · doi:10.1002/1097-0142(19830701)52:1<44::aid-cncr2820520110>3.0.co;2-v · Cited by 97
Self-citationPrognostic factors in 281 children with nonmetastatic rhabdomyosarcoma (RMS) at diagnosis
Rodary, C., Rey, A., Olive, D., Flamant, F., Quintana, E., Brunat-Mentigny, M., Otten, J., & Voûte, P. A. (1988) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950160202 · Cited by 64
Cited by
Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease
Crist, W. M., Anderson, J. R., Meza, J. L., Fryer, C., Raney, R. B., Ruymann, F. B., Breneman, J., Qualman, S. J., Wiener, E., Wharam, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.12.3091 · Cited by 1,087
Self-citationThe Third Intergroup Rhabdomyosarcoma Study.
Crist, W., Gehan, E. A., Ragab, A. H., Dickman, P. S., Donaldson, S. S., Fryer, C., Hammond, D., Hays, D. M., Herrmann, J., & Heyn, R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.3.610 · Cited by 999
Self-citationSkapek, S. X., Ferrari, A., Gupta, A. A., Lupo, P. J., Butler, E., Shipley, J., Barr, F. G., & Hawkins, D. S. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0051-2 · Cited by 875
Sorensen, P. H. B., Lynch, J. C., Qualman, S. J., Tirabosco, R., Lim, J. F., Maurer, H. M., Bridge, J. A., Crist, W. M., Triche, T. J., & Barr, F. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.137 · Cited by 742
Self-citationCommon Musculoskeletal Tumors of Childhood and Adolescence
Arndt, C. A. S., & Crist, W. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907293410507 · Cited by 657
Self-citationBreneman, J. C., Lyden, E., Pappo, A. S., Link, M. P., Anderson, J. R., Parham, D. M., Qualman, S. J., Wharam, M. D., Donaldson, S. S., Maurer, H. M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.129 · Cited by 470
Self-citationRhabdomyosarcoma in adults: A retrospective analysis of 171 patients treated at a single institution
Ferrari, A., Dileo, P., Casanova, M., Bertulli, R., Meazza, C., Gandola, L., Navarria, P., Collini, P., Gronchi, A., Olmi, P., et al. (2003) · Cancer · doi:10.1002/cncr.11550 · Cited by 403
Raney, R. B., Anderson, J. R., Barr, F. G., Donaldson, S. S., Pappo, A. S., Qualman, S. J., Wiener, E. S., Maurer, H. M., & Crist, W. M. (2001) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200105000-00008 · Cited by 376
Self-citationDavicioni, E., Graf Finckenstein, F., Shahbazian, V., Buckley, J. D., Triche, T. J., & Anderson, M. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4578 · Cited by 308
Prevalence and Spectrum of Germline Mutations of the p53 Gene among Patients with Sarcoma
Toguchida, J., Yamaguchi, T., Dayton, S. H., Beaughamp, R. L., Herrera, G. E., Ishizaki, K., Yamamuro, T., Meyers, P. A., Little, J. B., Sasaki, M. S., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262001 · Cited by 307
Common Musculoskeletal Tumors of Childhood and Adolescence
Arndt, C. A. S., Rose, P. S., Folpe, A. L., & Laack, N. N. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.01.015 · Cited by 298
Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis
Davicioni, E., Anderson, M. J., Finckenstein, F. G., Lynch, J. C., Qualman, S. J., Shimada, H., Schofield, D. E., Buckley, J. D., Meyer, W. H., Sorensen, P. H. B., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080631 · Cited by 297
O'Leary, M., Krailo, M., Anderson, J. R., & Reaman, G. H. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.07.008 · Cited by 293
Skubitz, K. M., & D'Adamo, D. R. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1409 · Cited by 277
Pappo, A. S., Anderson, J. R., Crist, W. M., Wharam, M. D., Breitfeld, P. P., Hawkins, D., Raney, R. B., Womer, R. B., Parham, D. M., Qualman, S. J., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3487 · Cited by 275
Self-citationKoscielniak, E., Rodary, C., Flamant, F., Carli, M., Treuner, J., Pinkerton, C. R., & Grotto, P. (1992) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950200305 · Cited by 83
Metadata
- Authors
- Crist, W. M., Garnsey, L., Beltangady, M. S., Gehan, E., Ruymann, F., Webber, B., Hays, D. M., Wharam, M., & Maurer, H. M.
- Venue
- Journal of Clinical Oncology
- Published
- 1990-03
- Volume
- 8
- Issue
- 3
- Pages
- 443-452
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1897723143
- Cited by
- 286
- References
- 6
- FWCI
- 19.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.